U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239297) titled 'Retrospective Pathology Foundation Models' on Nov. 16.
Brief Summary: By integrating retrospective multimodal data such as pathology and imaging, AI technologies offer novel solutions for disease classification, tumor grading, histological and molecular subtyping, selection of chemotherapy regimens, risk stratification, and treatment-response prediction. This research direction not only deepens our understanding of tumor biological characteristics but also provides essential support for precision medicine and individualized therapy. It holds significant theoretical and practical value and has important implications for mitigating st...